CLINICAL_TRIALS
trial_result
· 2013-06-24
Clinical Trial Update: SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer [Phase 2]
Summary
A phase 2 trial evaluating SU5416 for persistent or recurrent cervical cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gynecologic Oncology Group | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED